△ 第79回日本血液学会学術集会

第79回日本血液学会学術集会 が2017/10/20-22の日程にて東京国際フォーラムで開催され、CML-CSGより口説3演題、図説3演題を報告しました。抄録などの詳細は、それぞれの発表をクリックしてください。

★ OS3-14A-2
Incidence of second malignancies of chronic myeloid leukemia during TKI treatment
○Tomonori Nakazato, Noriyoshi Iriyama, Michihide Tokuhira, Maho Ishikawa, Eriko Sato, Tomoiku Takaku, Kei-Ji Sugimoto, Hiroyuki Fujita, Isao Fujioka, Norio Komatsu, Norio Asou, Masahiro Kizaki, Yoshihiro Hatta, Tatsuya Kawaguchi.

★ OS3-14A-3 
Analysis of vascular adverse events in TKI treated large cohort Japanese CML patients

Isao Fujioka, Tomoiku Takaku, Noriyoshi Iriyama, Michihide Tokuhira, Eriko Sato, Maho Ishikawa, Tomonori Nakazato, Kei-Ji Sugimoto, Hiroyuki Fujita, Norio Asou, Masahiro Kizak, Yoshihiro Hatta, Norio Komatsu, Tatsuya Kawaguchi.

★ OS3-14A-4
Efficacy and safety of the reduced dasatinib therapy in patients with chronic myeloid leukemia

○Yuta Kimura, Tomoiku Takaku, Noriyoshi Iriyama, Eriko Sato, Tomonori Nakazato, Kei-Ji Sugimoto, Hiroyuki Fujita, Maho Ishikawa, Isao Fujioka, Michihide Tokuhira, Norio Asou, Yoshihiro Hatta, Norio Komatsu, Tatsuya Kawaguchi.

★ PS2-8-4
Analysis of contributing factors to lymphocytosis during dasatinib therapy for CML 

Kei-Ji Sugimoto, Noriyoshi Iriyama, Isao Fujioka, Tomoiku Takaku, Eriko Sato, Maho Ishikawa, Tomonori Nakazato, Hiroyuki Fujita, Masahiro Kizaki, Norio Komatsu, Norio Asou, Yoshihiro Hatta, Michihide Tokuhira, Tatsuya Kawaguchi.

★ PS2-9-3
The introduction of 2nd TKIs may reduce the prognostic impact of EUTOS high-risk patients
Eriko Sato, Noriyoshi Iriyama, Michihide Tokuhira, Tomoiku Takaku, Maho Ishikawa, Tomonori Nakazato, Kei-Ji Sugimoto, Hiroyuki Fujita, Isao Fujioka, Norio Asou, Norio Komatsu, Masahiro Kizak, Yoshihiro Hatta, Tatsuya Kawaguchi.

★ PS2-9-4
Efficacy and safety of the reduced nilotinib therapy in patients with chronic myeloid leukemia 

Michihide Tokuhira, Kei-Ji Sugimoto, Tomonori Nakazato, Maho Ishikawa, Isao Fujioka, Tomoiku Takaku, Noriyoshi Iriyama, Eriko Sato, Hiroyuki Fujita, Norio Asou, Yoshihiro Hatta, Norio Komatsu, Tatsuya Kawaguchi.